Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The N-terminal domain (NTD) is a subdomain within the S1 region of the spike (S) glycoprotein of SARS-CoV-2. It is located at the extreme N-terminal end of each S1 subunit. While not directly responsible for ACE2 binding, it is a target for neutralizing antibodies and mutations or deletions in certain regions have been associated with altered infectivity or immune escape. The NTD plays a role in viral entry, immune evasion, and structural stabilization of the spike protein.
Neutralization of viral entry by antibody binding
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on N-terminal Domain of Spike Glycoprotein of SARS-CoV-2 (NTD).